Management Profile

Mr. Saldanha is the founder and promoter of the company. Prior to Marksans, he had been associated with Glenmark Pharmaceuticals Ltd. as a Whole Time Director. He is an integral force in the overall management of the company and possesses a vast amount of hands-on experience in marketing, production, finance and R&D.

Mrs. Saldanha is well-versed in the fields of Human Resource Management, Business Development, Projects and Supply Chain Management. She holds a Master’s Degree in Arts (Sociology).

Mr. Jain is a seasoned pharmaceutical professional with a robust technical background. With a wealth of experience gained from working with diverse multinational organizations, his expertise spans manufacturing, quality research and development, compliance, and regulatory affairs for both Active Pharmaceutical Ingredients (API) and finished dosage forms.

Mr. Mohammed has over 20+ years of experience in pharma innovation, operations, and distribution. Prior to Nova Pharmaceuticals, he was the Managing Director Australasia and Marketing Director Asia, Africa, and Australasia at Valeant Pharmaceuticals for over 7 years.

Mr. Sathish Kumar is the Managing Director of Marksans Pharma (UK) Ltd. & manages the affairs of Bells & Sons (Druggists) Ltd and Relonchem Ltd, both step-down operating subsidiaries of Marksans Pharma (UK) Ltd. He has over 20 years of experience in the Pharma industry working across Production, Planning and Inventory Management, Formulation development, Regulatory, Technical, Commercial, Sales and Business development. He holds an M. Pharm degree.

Mr. Kumar is an integral force in Marksans US operations. He has over 38 years of experience in all aspects of pharma management. His prior experience was in prestigious companies such as Wockhardt, Cipla, and Lupin. He has completed his Bachelor in Pharmaceuticals (B.Pharm).

Mr. Sharma is a qualified chartered accountant and cost accountant with over 20 years of experience in financial functions including treasury and forex management. His expertise in the areas of costing, fundraising, and internal control systems has been invaluable. He is a Director in MPL’s subsidiaries, Marksans Pharma (UK) Ltd, Marksans Pharma Inc. (USA), Nova Pharmaceuticals, Australia, and Relonchem, UK.